
MRM Valuation
Medirom Healthcare Technologies Inc
- Overview
- Forecast
- Valuation
- Earnings
MRM Relative Valuation
MRM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MRM is overvalued; if below, it's undervalued.
Historical Valuation
Medirom Healthcare Technologies Inc (MRM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.25 is considered Fairly compared with the five-year average of 0.00. The fair price of Medirom Healthcare Technologies Inc (MRM) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.80
Fair
0.00
PE
1Y
3Y
5Y
Trailing
Forward
12.59
EV/EBITDA
Medirom Healthcare Technologies Inc. (MRM) has a current EV/EBITDA of 12.59. The 5-year average EV/EBITDA is 1.35. The thresholds are as follows: Strongly Undervalued below -5.73, Undervalued between -5.73 and -2.19, Fairly Valued between 4.90 and -2.19, Overvalued between 4.90 and 8.44, and Strongly Overvalued above 8.44. The current Forward EV/EBITDA of 12.59 falls within the Strongly Overvalued range.
18.26
EV/EBIT
Medirom Healthcare Technologies Inc. (MRM) has a current EV/EBIT of 18.26. The 5-year average EV/EBIT is 2.23. The thresholds are as follows: Strongly Undervalued below -9.43, Undervalued between -9.43 and -3.60, Fairly Valued between 8.06 and -3.60, Overvalued between 8.06 and 13.89, and Strongly Overvalued above 13.89. The current Forward EV/EBIT of 18.26 falls within the Strongly Overvalued range.
0.25
PS
Medirom Healthcare Technologies Inc. (MRM) has a current PS of 0.25. The 5-year average PS is 0.02. The thresholds are as follows: Strongly Undervalued below -0.09, Undervalued between -0.09 and -0.03, Fairly Valued between 0.07 and -0.03, Overvalued between 0.07 and 0.13, and Strongly Overvalued above 0.13. The current Forward PS of 0.25 falls within the Strongly Overvalued range.
0.00
P/OCF
Medirom Healthcare Technologies Inc. (MRM) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
Medirom Healthcare Technologies Inc. (MRM) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Medirom Healthcare Technologies Inc (MRM) has a current Price-to-Book (P/B) ratio of 2.38. Compared to its 3-year average P/B ratio of -6.48 , the current P/B ratio is approximately -136.68% higher. Relative to its 5-year average P/B ratio of -3.97, the current P/B ratio is about -159.92% higher. Medirom Healthcare Technologies Inc (MRM) has a Forward Free Cash Flow (FCF) yield of approximately -61.35%. Compared to its 3-year average FCF yield of -43.39%, the current FCF yield is approximately 41.40% lower. Relative to its 5-year average FCF yield of -31.93% , the current FCF yield is about 92.14% lower.
2.24
P/B
Median3y
-6.48
Median5y
-3.97
-63.28
FCF Yield
Median3y
-43.39
Median5y
-31.93
Competitors Valuation Multiple
The average P/S ratio for MRM's competitors is 0.45, providing a benchmark for relative valuation. Medirom Healthcare Technologies Inc Corp (MRM) exhibits a P/S ratio of 0.25, which is -44.91% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MRM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of MRM in the past 1 year is driven by Unknown.
People Also Watch

ENSC
Ensysce Biosciences Inc
2.090
USD
-0.48%

OTRK
Ontrak Inc
0
USD
-13.64%

WTO
Utime Ltd
0.891
USD
+2.41%

DOMH
Dominari Holdings Inc
6.420
USD
+2.72%

STRR
Star Equity Holdings Inc
0
USD
0.00%

CNSP
CNS Pharmaceuticals Inc
6.200
USD
-1.04%

CHEK
Check Cap Ltd
0.734
USD
+13.99%

WAFU
Wah Fu Education Group Ltd
1.460
USD
-0.34%

KAVL
Kaival Brands Innovations Group Inc
1.000
USD
+12.11%
FAQ

Is Medirom Healthcare Technologies Inc (MRM) currently overvalued or undervalued?
Medirom Healthcare Technologies Inc (MRM) is now in the Fair zone, suggesting that its current forward PS ratio of 0.25 is considered Fairly compared with the five-year average of 0.00. The fair price of Medirom Healthcare Technologies Inc (MRM) is between to according to relative valuation methord.

What is Medirom Healthcare Technologies Inc (MRM) fair value?

How does MRM's valuation metrics compare to the industry average?

What is the current P/B ratio for Medirom Healthcare Technologies Inc (MRM) as of Aug 30 2025?

What is the current FCF Yield for Medirom Healthcare Technologies Inc (MRM) as of Aug 30 2025?

What is the current Forward P/E ratio for Medirom Healthcare Technologies Inc (MRM) as of Aug 30 2025?
